RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS

Introduction. The anthracycline antibiotics cause clinically significant manifestations of cardiotoxicity (СТ) – myocardial injuries, reducing both quality and life expectancy of the oncological patients.The purpose of the study was to evaluate the incidence and risk factors anthracycline-induced СТ...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: N. T. Vatutin, E. V. Sklyannaya, M. A. El-Khatib, I. A. Sologub
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: ABV-press 2017-10-01
Saila:Onkogematologiâ
Gaiak:
chemotherapy
cardiotoxicity
anthracycline-induced cardiomyopathy
risk factors
cardioprotection
Sarrera elektronikoa:https://oncohematology.abvpress.ru/ongm/article/view/255
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak